A key signaling nexus in breast cancer is the receptor tyrosine kinase HER2, also called ERBB2, which is upregulated in 25% of breast cancer cases and promotes metastasis, partially by activating HSF1 [82,107]. Here, ERBB2 is linked to breast carcinoma.